Trial intelligence / Profile preview

Guanfacine for Alcohol Use Disorder (AUD): a Telehealth Approach

NCT06629259Phase 2Recruiting

Sponsor
Indiana University
Start
Oct 2025
Primary completion
Aug 2029
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of guanfacine in alcohol use disorder (AUD), sponsored by Indiana University. Started Oct 2025; status: recruiting.

02

Drugs

guanfacine
03

Conditions

alcohol use disorder (AUD)

Beyond the preview

Go deeper on NCT06629259.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06629259.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call